Implementing a Scalable Healthcare Community Funding Solution for a Global Biopharma Partner

The organization faced increasing complexity in managing funding activities due to:

• Fragmented, manual processes requiring significant administrative effort
• Limited visibility into funding requests, approvals, and supporting documentation
• Inconsistent processes across regions and programs
• Growing compliance and audit requirements within a global regulatory environment
• Rising request volumes that strained existing operating models

A more standardized, transparent, and scalable solution was required to support both operational efficiency and governance.

Osprey Life Sciences partnered as a strategic program and delivery lead to design and implement a global Healthcare Community Funding capability. The approach included:

• Designing a standardized, end-to-end funding lifecycle from intake through closeout
• Establishing a global operating model with defined governance frameworks
• Configuring and implementing the IQVIA Healthcare Community Funding platform (GFMS)
• Aligning cross-functional stakeholders across Medical Affairs, Commercial, Legal, Compliance, Finance, and IT
• Supporting change management, user enablement, and post-launch stabilization

This integrated approach combined process design, platform implementation, and stakeholder alignment to ensure a scalable and compliant solution.

The transformation delivered measurable operational and strategic value:

• Centralized request intake and standardized workflows reduced administrative burden and rework
• Improved visibility into funding activities strengthened governance and audit readiness
• Accelerated review and approval timelines enhanced operational efficiency
• Consistent global processes enabled scalable program growth
• Streamlined experience improved engagement for both internal users and external partners

The organization now operates with a more efficient, transparent, and sustainable model for managing global healthcare funding.

Client Feedback:

Initial stakeholder feedback has been positive, including approval of launch materials, confirmation of go-live support, and early indicators of adoption of the platform over legacy and manual approaches.

​